Search

Your search keyword '"Bogani, Giorgio"' showing total 1,319 results
Start Over Author "Bogani, Giorgio"
1,319 results on '"Bogani, Giorgio"'

52. Survival outcomes in endometrial cancer patients having lymphadenectomy, sentinel node mapping followed by lymphadectomy and sentinel node mapping alone: Long-term results of a propensity-matched analysis

Author

Bogani, Giorgio, Casarin, Jvan, Leone Roberti Maggiore, Umberto, Ditto, Antonino, Pinelli, Ciro, Dell'acqua, Andrea, Lopez, Salvatore, Chiappa, Valentina, Brusadelli, Claudia, Guerrisi, Rocco, Ferrero, Simone, Ghezzi, Fabio, and Raspagliesi, Francesco

Published
2020
Full Text
View/download PDF

56. Concurrent Endometrial Cancer in Women with Atypical Endometrial Hyperplasia: What Is the Predictive Value of Patient Characteristics?

Author

Giannella, Luca, primary, Piva, Francesco, additional, Delli Carpini, Giovanni, additional, Di Giuseppe, Jacopo, additional, Grelloni, Camilla, additional, Giulietti, Matteo, additional, Sopracordevole, Francesco, additional, Giorda, Giorgio, additional, Del Fabro, Anna, additional, Clemente, Nicolò, additional, Gardella, Barbara, additional, Bogani, Giorgio, additional, Brasile, Orsola, additional, Martinello, Ruby, additional, Caretto, Marta, additional, Ghelardi, Alessandro, additional, Albanesi, Gianluca, additional, Stevenazzi, Guido, additional, Venturini, Paolo, additional, Papiccio, Maria, additional, Cannì, Marco, additional, Barbero, Maggiorino, additional, Fambrini, Massimiliano, additional, Maggi, Veronica, additional, Uccella, Stefano, additional, Spinillo, Arsenio, additional, Raspagliesi, Francesco, additional, Greco, Pantaleo, additional, Simoncini, Tommaso, additional, Petraglia, Felice, additional, and Ciavattini, Andrea, additional

Published
2023
Full Text
View/download PDF

57. Spotlight on compounded bioidentical hormones

Author

Santangelo, Giusi, primary, Lagana, Antonio Simone, additional, Giannini, Andrea, additional, Murina, Filippo, additional, Di Dio, Camilla, additional, Ruggiero, Gianfilippo, additional, Di Donato, Violante, additional, Perniola, Giorgia, additional, Fischetti, Margherita, additional, Casorelli, Assunta, additional, Clemente, Francesco Francesco, additional, Minnetti, Marianna, additional, Lombardo, Francesco, additional, Panici, Pierluigi Benedetti, additional, Muzii, Ludovico, additional, and Bogani, Giorgio, additional

Published
2023
Full Text
View/download PDF

58. Robotic vs. laparoscopic approach in obese patients with endometrial cancer: which is the best? A mini-review

Author

Golia D’Augè, Tullio, primary, Cuccu, Ilaria, additional, De Angelis, Emanuele, additional, Buzzaccarini, Giovanni, additional, D’Oria, Ottavia, additional, Besharat, Aris Raad, additional, Caserta, Donatella, additional, Muzii, Ludovico, additional, Bogani, Giorgio, additional, Di Donato, Violante, additional, and Giannini, Andrea, additional

Published
2023
Full Text
View/download PDF

59. Clinicopathological characteristics of multiple-classifier endometrial cancers: a cohort study and systematic review

Author

De Vitis, Luigi Antonio, primary, Schivardi, Gabriella, additional, Caruso, Giuseppe, additional, Fumagalli, Caterina, additional, Vacirca, Davide, additional, Achilarre, Maria Teresa, additional, Aloisi, Alessia, additional, Garbi, Annalisa, additional, Zanagnolo, Vanna, additional, Aletti, Giovanni, additional, Guerini-Rocco, Elena, additional, Mariani, Andrea, additional, Maggioni, Angelo, additional, Barberis, Massimo, additional, Bogani, Giorgio, additional, Colombo, Nicoletta, additional, Multinu, Francesco, additional, and Betella, Ilaria, additional

Published
2023
Full Text
View/download PDF

60. Prognostic value of isolated tumor cells in sentinel lymph nodes in low risk endometrial cancer: results from an international multi-institutional study

Author

Cucinella, Giuseppe, primary, Schivardi, Gabriella, additional, Zhou, Xun Clare, additional, AlHilli, Mariam, additional, Wallace, Sumer, additional, Wohlmuth, Christoph, additional, Baiocchi, Glauco, additional, Tokgozoglu, Nedim, additional, Raspagliesi, Francesco, additional, Buda, Alessandro, additional, Zanagnolo, Vanna, additional, Zapardiel, Ignacio, additional, Jagasia, Nisha, additional, Giuntoli, Robert, additional, Glickman, Ariel, additional, Peiretti, Michele, additional, Lanner, Maximilian, additional, Chacon, Enrique, additional, Di Guilmi, Julian, additional, Pereira, Augusto, additional, Laas-Faron, Enora, additional, Fishman, Ami, additional, Nitschmann, Caroline C, additional, Kurnit, Katherine, additional, Moriarty, Kristen, additional, Joehlin-Price, Amy, additional, Lees, Brittany, additional, Covens, Allan, additional, De Brot, Louise, additional, Taskiran, Cagatay, additional, Bogani, Giorgio, additional, Landoni, Fabio, additional, Grassi, Tommaso, additional, Paniga, Cristiana, additional, Multinu, Francesco, additional, De Vitis, Luigi Antonio, additional, Hernández, Alicia, additional, Mastroyannis, Spyridon, additional, Ghoniem, Khaled, additional, Chiantera, Vito, additional, Shahi, Maryam, additional, Fought, Angela J, additional, McGree, Michaela, additional, Mariani, Andrea, additional, and Glaser, Gretchen, additional

Published
2023
Full Text
View/download PDF

70. Hormone replacement therapy in gynecological cancer survivors and BRCA mutation carriers: a MITO group survey.

Author

Palaia, Innocenza, Caruso, Giuseppe, Di Donato, Violante, Turetta, Camilla, Savarese, Antonella, Perniola, Giorgia, Gallo, Roberta, Giannini, Andrea, Salutari, Vanda, Bogani, Giorgio, Tomao, Federica, Giannarelli, Diana, Gentile, Gabriella, Musella, Angela, Muzii, Ludovico, and Pignata, Sandro

Subjects
HORMONE therapy, CANCER survivors, MEDICAL personnel, BRCA genes, GYNECOLOGIC care, CANCER treatment
Abstract

Objective: Early iatrogenic menopause in gynecological cancer survivors and BRCA mutation (BRCAm) carriers undergoing risk-reducing salpingo-oophorectomy (RRSO) is a major health concern. Hormone replacement therapy (HRT) is the most effective remedy, but remains underused in clinical practice. The Multicenter Italian Trials in Ovarian cancer and gynecologic malignancies (MITO) group promoted a national survey to investigate the knowledge and attitudes of healthcare professionals regarding the prescription of HRT. Methods: The survey consisted of a self-administered, multiple-choice 45-item questionnaire, available online to all MITO members for 2 months starting from January 2022. Results: A total of 61 participants completed the questionnaire (47 out of 180 MITO centers; compliance: 26.1%). Most respondents were female (73.8%), younger than 50 years (65.6%), and gynecologic oncologists (55.7%), working in public general hospitals (49.2%). An 84.4% of specialists actively discuss HRT with patients and 51.0% of patients ask the specialist for an opinion on HRT. The rate of specialists globally in favor of prescribing HRT was 22.9% for ovarian cancer, 49.1% for cervical cancer, and 8.2% for endometrial cancer patients. Most respondents (70.5%) believe HRT is safe for BRCA-mutated patients after RRSO. Nearly 70% of physicians prescribe systemic HRT, while 23.8% prefer local HRT. Most specialists recommend HRT for as long as there is a benefit and generally for up to 5 years. Conclusion: Real-world data suggest that many healthcare professionals still do not easily prescribe HRT for gynecological cancer survivors and BRCA mutation carriers after RRSO. Further efforts are required to implement the use of HRT in clinical practice and to support both clinicians in recommending HRT and patients in accepting it. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

72. Long-Term Follow-Up Outcomes in Women with In Situ/Microinvasive Adenocarcinoma of the Uterine Cervix Undergoing Conservative Treatment—Cervical Adenocarcinoma Study Group Italian Society of Colposcopy and Cervico-Vaginal Pathology.

Author

Giannella, Luca, Delli Carpini, Giovanni, Di Giuseppe, Jacopo, Grelloni, Camilla, Bogani, Giorgio, Dri, Marco, Sopracordevole, Francesco, Clemente, Nicolò, Giorda, Giorgio, De Vincenzo, Rosa, Evangelista, Maria Teresa, Gardella, Barbara, Dominoni, Mattia, Monti, Ermelinda, Alessi, Chiara, Alessandrini, Lara, Guerriero, Angela, Pagan, Alessio, Caretto, Marta, and Ghelardi, Alessandro

Subjects
ADENOCARCINOMA, CONSERVATIVE treatment, UTERINE tumors, CERVIX uteri tumors, CANCER invasiveness, VAGINA, LOGISTIC regression analysis, EVALUATION of medical care, TREATMENT effectiveness, RETROSPECTIVE studies, KAPLAN-Meier estimator, LOG-rank test, ODDS ratio, LONGITUDINAL method, COLPOSCOPY, RESEARCH methodology, WOMEN'S health, CONFIDENCE intervals, DATA analysis software, SURVIVAL analysis (Biometry), CARCINOMA in situ, PATIENT aftercare, CERVIX uteri
Abstract

Simple Summary: In situ/microinvasive adenocarcinoma of the uterine cervix represents the majority of cervical glandular lesions and can be treated conservatively. In contrast to squamous lesions, approximately 15–20% of glandular disease may be HPV-negative and therefore associated with a worse prognosis. Furthermore, up to 4% of cases may show recurrence after three years of follow-up. Given the abovementioned risk, knowing the predictive factors of disease recurrence becomes crucial for post-treatment management. In the present study, HPV testing in follow-up was the best predictor for recurrences in women with in situ/microinvasive AC undergoing conservative treatment. So, its use in clinical practice is of pivotal importance. However, attention should be paid to non-high-risk HPV women in follow-up with non-usual-type histopathology, given that it seems to represent a sub-population at increased risk of recurrences. Objective: The present study aimed to assess long-term follow-up outcomes in women with in situ/microinvasive adenocarcinoma (AC) of the uterine cervix treated conservatively. Methods: Retrospective multi-institutional study including women with early glandular lesions and 5-year follow-up undergoing fertility-sparing treatment. Independent variables associated with recurrence were evaluated. Logistic regression analysis and Kaplan–Meier survival analysis with Logrank test were performed. Results: Of 269 women diagnosed with in situ/microinvasive AC, 127 participants underwent conservative treatment. During follow-up, recurrences were found in nine women (7.1%). The only factor associated with recurrence during follow-up was positive high-risk Human Papillomavirus (hr-HPV) testing (odds ratio 6.21, confidence interval 1.47–26.08, p = 0.012). HPV positivity in follow-up showed a recurrence rate of 21.7% against 3.8% in patients who were HPV-negative (p = 0.002, Logrank test). Among women with negative high-risk HPV tests in follow-up, recurrences occurred in 20.0% of non-usual-type histology vs. 2.1% of usual-type cases (p = 0.005). Conclusion: HPV testing in follow-up is of pivotal importance in women with early glandular lesions undergoing conservative treatment, given its recurrence predictive value. However, women who are high-risk HPV-negative in follow-up with non-usual-type histopathology may represent a sub-population at increased risk of recurrences. Further studies should confirm these findings. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

74. Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial

Author

Di Liello, Raimondo, Arenare, Laura, Raspagliesi, Francesco, Scambia, Giovanni, Pisano, Carmela, Colombo, Nicoletta, Frezzini, Simona, Tognon, Germana, Artioli, Grazia, Gadducci, Angiolo, Lauria, Rossella, Ferrero, Annamaria, Cinieri, Saverio, De Censi, Andrea, Breda, Enrico, Scollo, Paolo, De Giorgi, Ugo, Lissoni, Andrea Alberto, Katsaros, Dionyssios, Lorusso, Domenica, Salutari, Vanda, Cecere, Sabrina Chiara, Lapresa, Mariateresa, Nardin, Margherita, Bogani, Giorgio, Distefano, Mariagrazia, Greggi, Stefano, Gargiulo, Piera, Schettino, Clorinda, Gallo, Ciro, Daniele, Gennaro, Califano, Daniela, Perrone, Francesco, Pignata, Sandro, and Piccirillo, Maria Carmela

Published
2021
Full Text
View/download PDF

76. EP108/#409 Multiple classifier endometrial cancer: a multicenter study

Author

Bogani, Giorgio, primary, Casarin, Jvan, additional, Betella, Ilaria, additional, Multinu, Fancesco, additional, Ghezzi, Fabio, additional, Schivardi, Gabriella, additional, Vitis, Luigi De, additional, Berretta, Roberto, additional, Vizzielli, Giuseppe, additional, Petrillo, Marco, additional, Sorbi, Flavia, additional, Colombo, Nicoletta, additional, Longo, Mariangela, additional, Donato, Violante Di, additional, and Raspagliesi, Francesco, additional

Published
2023
Full Text
View/download PDF

78. PR006/#38 Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for ‘low-risk’ early-stage cervical cancer: a propensity-score based analysis

Author

Bogani, Giorgio, primary, Raspagliesi, Francesco, additional, Malzoni, Mario, additional, Longo, Mariangela, additional, Ervas, Elisa, additional, Casarin, Jvan, additional, Plotti, Francesco, additional, Angioli, Roberto, additional, Cuccu, Ilaria, additional, Turetta, Camilla, additional, Golia D’Auge, Tullio, additional, and Donato, Violante Di, additional

Published
2023
Full Text
View/download PDF

79. Characteristics and outcomes of surgically staged multiple classifier endometrial cancer

Author

Bogani, Giorgio, primary, Betella, Ilaria, additional, Multinu, Francesco, additional, Casarin, Jvan, additional, GhezzI, Fabio, additional, Sorbi, Flavia, additional, VizziellI, Giuseppe, additional, Petrillo, Marco, additional, Cianci, Stefano, additional, Berretta, Roberto, additional, PaolinI, Biagio, additional, FanfanI, Francesco, additional, De Vitis, Luigi, additional, Scambia, Giovanni, additional, Mariani, Andrea, additional, Colombo, Nicoletta, additional, and Raspagliesi, Francesco, additional

Published
2023
Full Text
View/download PDF

81. Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study

Author

Mangili, Giorgia, Giorda, Giorgio, Ferrandina, Gabriella, Cormio, Gennaro, Cassani, Chiara, Savarese, Antonella, Danese, Saverio, Carnelli, Marco, Vasta, Francesca Maria, Perrone, Anna Myriam, Scarfone, Giovanna, Pignata, Sandro, Legge, Francesco, Raspagliesi, Francesco, Taccagni, Gianluca, Candiani, Massimo, Bogani, Giorgio, Mascilini, Floriana, and Bergamini, Alice

Published
2021
Full Text
View/download PDF

82. Using Radiomics and Machine Learning Applied to MRI to Predict Response to Neoadjuvant Chemotherapy in Locally Advanced Cervical Cancer

Author

Chiappa, Valentina, primary, Bogani, Giorgio, additional, Interlenghi, Matteo, additional, Vittori Antisari, Giulia, additional, Salvatore, Christian, additional, Zanchi, Lucia, additional, Ludovisi, Manuela, additional, Leone Roberti Maggiore, Umberto, additional, Calareso, Giuseppina, additional, Haeusler, Edward, additional, Raspagliesi, Francesco, additional, and Castiglioni, Isabella, additional

Published
2023
Full Text
View/download PDF

83. Gestational choriocarcinoma

Author

Bogani, Giorgio, primary, Ray-Coquard, Isabelle, additional, Mutch, David, additional, Vergote, Ignace, additional, Ramirez, Pedro T, additional, Prat, Jaime, additional, Concin, Nicole, additional, Ngoi, Natalie Yan Li, additional, Coleman, Robert L, additional, Enomoto, Takayuki, additional, Takehara, Kazuhiro, additional, Denys, Hannelore, additional, Lorusso, Domenica, additional, Takano, Masashi, additional, Sagae, Satoru, additional, Wimberger, Pauline, additional, Segev, Yakir, additional, Kim, Se Ik, additional, Kim, Jae-Weon, additional, Herrera, Fernanda, additional, Mariani, Andrea, additional, Brooks, Rebecca A, additional, Tan, David, additional, Paolini, Biagio, additional, Chiappa, Valentina, additional, Longo, Mariangela, additional, Raspagliesi, Francesco, additional, Benedetti Panici, Pierluigi, additional, Di Donato, Violante, additional, Caruso, Giuseppe, additional, Colombo, Nicoletta, additional, Pignata, Sandro, additional, Zannoni, Gianfranco, additional, Scambia, Giovanni, additional, and Monk, Bradley J, additional

Published
2023
Full Text
View/download PDF

87. #534 Prognosis of surgically staged FIGO IA uterine carcinosarcoma without myometrial invasion: a multicenter international retrospective cohort study

Author

Cucinella, Giuseppe, primary, Zammarrelli, William A, additional, Nasioudis, Dimitrios, additional, Capasso, Ilaria, additional, Berretta, Roberto, additional, Scollo, Paolo, additional, Francesco, Raspagleisi, additional, Baiocchi, Glauco, additional, Barresi, Giuseppe, additional, Basilio, Pecorino, additional, Bogani, Giorgio, additional, Goncalves, Bruna Tirapelli, additional, Shahi, Maryam, additional, Fought, Angela J, additional, Mcgree, Michaela E, additional, Chiantera, Vito, additional, Fanfani, Francesco, additional, Scambia, Giovanni, additional, Abu-Rustum, Nadeem R, additional, Mariani, Andrea, additional, Giuntoli, Robert, additional, Glaser, Gretchen, additional, and Leitao, Mario M, additional

Published
2023
Full Text
View/download PDF

89. #427 Ten-year outcomes following laparoscopic and open abdominal radical hysterectomy for ‘low-risk’ early-stage cervical cancer: a propensity-score based analysis

Author

D’augè, Tullio Golia, primary, Donato, Violante Di, additional, Bogani, Giorgio, additional, Casarin, Jvan, additional, Ghezzi, Fabio, additional, Malzoni, Mario, additional, Falcone, Francesca, additional, Petrillo, Marco, additional, Capobianco, Giampiero, additional, Calò, Filippo, additional, Muzii, Ludovico, additional, Panici, Pierluigi Benedetti, additional, Ervas, Elisa, additional, Ditto, Antonino, additional, Raspagliesi, Francesco, additional, Sopracordevole, Francesco, additional, Vizza, Enrico, additional, and Giannini, Andrea, additional

Published
2023
Full Text
View/download PDF

90. Role of bevacizumab in uterine leiomyosarcoma

Author

Bogani, Giorgio, Ditto, Antonino, Martinelli, Fabio, Signorelli, Mauro, Chiappa, Valentina, Fonatella, Caterina, Sanfilippo, Roberta, Leone Roberti Maggiore, Umberto, Ferrero, Simone, Lorusso, Domenica, and Raspagliesi, Francesco

Published
2018
Full Text
View/download PDF

95. Comparison of a sentinel lymph node mapping algorithm and comprehensive lymphadenectomy in the detection of stage IIIC endometrial carcinoma at higher risk for nodal disease

Author

Ducie, Jennifer A., Eriksson, Ane Gerda Zahl, Ali, Narisha, McGree, Michaela E., Weaver, Amy L., Bogani, Giorgio, Cliby, William A., Dowdy, Sean C., Bakkum-Gamez, Jamie N., Soslow, Robert A., Keeney, Gary L., Abu-Rustum, Nadeem R., Mariani, Andrea, and Leitao, Mario M., Jr

Published
2017
Full Text
View/download PDF

98. Prevention, Screening, Treatment and Follow-Up of Gynecological Cancers: State of Art and Future Perspectives

Author

Golia D'Augè, Tullio, primary, Giannini, Andrea, primary, Bogani, Giorgio, primary, Di Dio, Camilla, primary, Laganà, Antonio Simone, primary, Di Donato, Violante, primary, Salerno, Maria Giovanna, primary, Caserta, Donatella, primary, Chiantera, Vito, primary, Vizza, Enrico, primary, Muzii, Ludovico, primary, and D’Oria, Ottavia, primary

Published
2023
Full Text
View/download PDF

100. HPV-related lesions after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer: A focus on the potential role of vaccination

Author

Bogani, Giorgio, Sopracordevole, Francesco, Ciavattini, Andrea, Ghelardi, Alessandro, Vizza, Enrico, Vercellini, Paolo, Casarin, Jvan, Pinelli, Ciro, Ghezzi, Fabio, De Vincenzo, Rosa, Di Donato, Violante, Golia D’augè, Tullio, Giannini, Andrea, Sorbi, Flavia, Petrillo, Marco, Capobianco, Giampiero, Vizzielli, Giuseppe, Restaino, Stefano, Cianci, Stefano, Scambia, Giovanni, and Raspagliesi, Francesco

Abstract

Objective: To date, no data supports the execution of vaccination after hysterectomy for high-grade cervical intraepithelial neoplasia (CIN2+) and early-stage cervical cancer. We aim to evaluate the potential effect of vaccination after hysterectomy for high-grade cervical intraepithelial neoplasia and early-stage cervical cancer.Methods: This is a multi-center retrospective study evaluating data of women who develop lower genital tract dysplasia (including anal, vulvar and vaginal intra-epithelial neoplasia) after having hysterectomy for CIN2+ and FIGO stage IA1- IB1 cervical cancer.Results: Overall, charts for 77 patients who developed lower genital tract dysplasia were collected. The study population included 62 (80.5%) and 15 (19.5%) patients with CIN2+ and early-stage cervical cancer, respectively. The median (range) time between hysterectomy and diagnosis of develop lower genital tract dysplasia was 38 (range, 14-62) months. HPV types covered by the nonavalent HPV vaccination would potentially cover 94.8% of the development of lower genital tract dysplasia. Restricting the analysis to the 18 patients with available HPV data at the time of hysterectomy, the beneficial effect of nonvalent vaccination was 89%. However, considering that patients with persistent HPV types (with the same HPV types at the time of hysterectomy and who developed lower genital tract dysplasia) would not benefit from vaccination, we estimated the potential protective effect of vaccination to be 67% (12 out of 18 patients; four patients had a persistent infection for the same HPV type(s)).Conclusions: Our retrospective analysis supported the adoption of HPV vaccination in patients having treatment for HPV-related disease. Even in the absence of the uterine cervix, HPV vaccination would protect against develop lower genital tract dysplasia. Further prospective studies have to confirm our preliminary research.

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results